PeptidePedia The community reference

Insulin syringe: difference between revisions

Diff·revision 19 → 20·11:10, 18 Apr 2025

Difference between revision 19 and revision 20 of Insulin syringe. 6 lines changed; the page grew by 556 bytes.

Revision 19 — 21:35, 1 Apr 2025
DiluentDiya (talk)
add the disclaimer that this is not administration guidance
4,111 bytes ±0
Revision 20 — 11:10, 18 Apr 2025
BacWaterBarnaby (talk)
the rounding in the table lost a decimal place that matters at low doses
4,667 bytes +556
36The historical U-40 and U-500 insulin concentrations, with syringes scaled to match, are the reason the unit convention exists at all and the reason mismatched syringe and concentration have caused documented harm in insulin therapy. That history is why the convention is worth understanding rather than working around.{{r|ada2024}}36The historical U-40 and U-500 insulin concentrations, with syringes scaled to match, are the reason the unit convention exists at all and the reason mismatched syringe and concentration have caused documented harm in insulin therapy. That history is why the convention is worth understanding rather than working around.{{r|ada2024}}
3737
+38== Needles ==
+39Needle gauge and length are chosen for the route. Subcutaneous administration uses short fine needles, typically 4–8 mm and 29–32 gauge in current practice; longer needles increase the chance of intramuscular delivery, which changes absorption. See [[Subcutaneous injection]].{{r|ada2024}}
+40
+41Fine needles are more comfortable but deliver more slowly and are more easily bent or blunted. A needle used once is sharp; a needle reused is not, and blunting is measurable after a single insertion.
+42
38== References ==43== References ==
39{{reflist}}44{{reflist}}
48* [[Subcutaneous injection]]53* [[Subcutaneous injection]]
49* [[Sharps disposal]]54* [[Sharps disposal]]
+55* [[Reconstitution of lyophilised peptides]]
5056
51{{DEFAULTSORT:Insulin syringe}}57{{DEFAULTSORT:Insulin syringe}}